The latest audited financial results for SRF Ltd for the quarter and year ended March 31, 2026, reveal a company undergoing a massive structural shift. While the top-line growth appears steady at 7.4% for FY26, the real story lies in the bottom line, where Net Profit (PAT) has skyrocketed by 46.7% to reach ₹ 1,835.2 crore.
However, beneath this veneer of profitability, a fierce tug-of-war is happening. On one side, the Chemicals Business is firing on all cylinders, contributing over 75% of the group’s EBIT. On the other, the management has slammed the brakes on a major ₹ 490 crore packaging capex, signaling a tactical retreat in a segment battered by Chinese overcapacity.
1. At a Glance
The numbers coming out of this diversified giant are nothing short of a financial thriller. We are looking at a company that generated ₹ 15,787 crore in revenue in FY26, yet its market valuation reflects a heavy reliance on a single engine: Chemicals.
The red flags are waving in the Performance Films (Packaging) segment. Despite a recovery in margins, the management’s sudden decision to defer the ₹ 490 crore BOPP facility in Indore indefinitely is a massive admission of the “operating environment” shifting against them. They are essentially saying that the risk-reward ratio in packaging has soured to a point where capital is better kept in the bank or diverted elsewhere.
Furthermore, the Specialty Chemicals division is locked in a brutal pricing war with China. Management admits to “irrational pricing” and a “pricing-led” growth shortfall. They are choosing to protect market share over margins, a move that keeps the factories running but puts a ceiling on near-term profitability. Investors are now watching a high-stakes game of chicken: who blinks first, SRF or the Chinese state-backed exporters?
The total assets of the firm have grown to ₹ 24,147 crore, but the Return on Capital Employed (ROCE) remains a modest 14.6%. For a company trading at over 5.7 times its book value, the market is demanding much higher capital efficiency. If the chemical engine stalls even slightly, the current P/E of 42.3 will look like a very expensive mistake.
2. Introduction
SRF Ltd is no longer just a “technical textiles” company. It is a chemical powerhouse that happens to make packaging films and tyre cords on the side. Founded in 1970, it has evolved into a global conglomerate with 16 manufacturing facilities across India, Thailand, South Africa, and Hungary.
The company is currently in the middle of a massive ₹ 12,000–13,000 crore capex cycle (FY24–FY28), primarily focused on the high-margin Chemicals segment. The geographical footprint is vast, with 55% of revenue coming from exports to over 90 countries. However, this global exposure is a double-edged sword. With the US reshaping its tariff policies and the Red Sea logistics crisis causing “unprecedented rupee depreciation,” SRF’s treasury department is working overtime.
The latest results show a company that is successfully navigating a “Kigali Amendment” transition, aiming to dominate the next generation of refrigerant gases. But as they double down on chemicals, they are quietly de-risking from their traditional strongholds.
3. Business Model – WTF Do They Even Do?
SRF operates like a portfolio of four distinct businesses that have very little in common except for their reliance on complex engineering.
- Chemicals (49% Revenue): This is the crown jewel. They make refrigerant gases (the stuff in your AC) and specialty intermediates for Pharma and Agro. They are essentially the “kitchen” for global giants, cooking up complex molecules that others can’t.
- Packaging Films (37% Revenue): They make the plastic films used to wrap everything from Lays
